Is BriaCell Therapeutics Corp. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is BriaCell Therapeutics Corp. in?▾
BriaCell Therapeutics Corp. (BCT.TO) operates in the Healthcare sector, specifically the Biotechnology industry.